指南与共识消化、代谢与肾脏急症

开发炎症性肠病以患者为中心的标准化结局集:一项国际跨学科共识

Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease-an International, Cross-disciplinary Consensus.
指南 / 共识 · J Crohns Colitis · 2018-01-01
一句话结论国际多学科共识制定了炎症性肠病(IBD)以患者为中心的标准化结局测量集,推荐单一患者报告结局测量工具(IBD-Control问卷),在基线和6或12个月间隔测量。

该国际共识由25名代表患者、患者协会、胃肠病学家、外科医生、专科护士、IBD登记处和患者报告结局测量(PROM)方法学家的成员参与,采用改良德尔菲过程、系统综述、登记数据、患者焦点小组和公开评议期,为年龄≥16岁的IBD患者制定了一套最低限度的标准化结局测量集。结局领域包括生存与疾病控制(生存、疾病活动/缓解、结直肠癌、贫血)、治疗负效用(治疗相关并发症)、医疗保健利用(IBD相关入院、急诊就诊)和患者报告结局(包括生活质量、营养状况和瘘管影响),在基线和6或12个月间隔测量。推荐单一PROM(IBD-Control问卷),并在基线和每年收集最低限度的风险调整数据:人口统计学、基本临床信息和治疗因素。该标准集为IBD提供了国际模板,旨在实现有意义、可比且易于解释的测量,以推进价值导向的医疗保健。

要点

  • 针对年龄≥16岁的IBD患者,国际共识制定了最低标准结局测量集,包括生存、疾病活动/缓解、结直肠癌、贫血等疾病控制指标。
  • 结局测量应在基线和6或12个月间隔进行,涵盖治疗相关并发症、IBD相关入院和急诊就诊等医疗保健利用指标。
  • 推荐使用单一PROM工具——IBD-Control问卷,并测量生活质量、营养状况和瘘管影响等患者报告结局。
  • 风险调整数据应在基线和每年收集,包括人口统计学、基本临床信息和治疗因素。
  • 该标准集基于证据、患者输入和专家共识,为IBD价值导向医疗保健提供国际模板。

适用人群与场景

  • 年龄≥16岁的炎症性肠病(IBD)患者,适用于不同医疗保健环境。

研究设计与关键结果

  • 国际工作组(n=25)包括患者、患者协会、胃肠病学家、外科医生、专科护士、IBD登记处和PROM方法学家,通过一系列电话会议参与改良德尔菲过程。
  • 采用系统综述、登记数据、患者焦点小组和公开评议期达成共识,确定最低标准结局测量集和风险调整变量。
  • 结局领域包括生存与疾病控制(生存、疾病活动/缓解、结直肠癌、贫血)、治疗负效用(治疗相关并发症)、医疗保健利用(IBD相关入院、急诊就诊)和患者报告结局(包括生活质量、营养状况和瘘管影响)。
  • 测量时间点为基线和6或12个月间隔。
  • 推荐单一PROM(IBD-Control问卷),风险调整数据在基线和每年收集:人口统计学、基本临床信息和治疗因素。

证据类型、等级与局限

  • 证据类型:国际跨学科共识(改良德尔菲过程)。
  • 方法:系统综述现有文献、登记数据、患者焦点小组和公开评议期。
  • 类似方法已用于其他21个疾病领域(www.ichom.org)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该标准集为IBD提供国际模板,用于有意义、可比且易于解释的结局测量,作为实现价值导向医疗保健的一步。
  • 推荐在基线和6或12个月间隔测量结局,基线和每年收集风险调整数据。
  • 推荐使用IBD-Control问卷作为单一PROM。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND AND AIMS: Success in delivering value-based healthcare involves measuring outcomes that matter most to patients. Our aim was to develop a minimum Standard Set of patient-centred outcome measures for inflammatory bowel disease [IBD], for use in different healthcare settings.

METHODS: An international working group [n = 25] representing patients, patient associations, gastroenterologists, surgeons, specialist nurses, IBD registries and patient-reported outcome measure [PROM] methodologists participated in a series of teleconferences incorporating a modified Delphi process. Systematic review of existing literature, registry data, patient focus groups and open review periods were used to reach consensus on a minimum set of standard outcome measures and risk adjustment variables. Similar methodology has been used in 21 other disease areas [www.ichom.org].

RESULTS: A minimum Standard Set of outcomes was developed for patients [aged ≥16] with IBD. Outcome domains included survival and disease control [survival, disease activity/remission, colorectal cancer, anaemia], disutility of care [treatment-related complications], healthcare utilization [IBD-related admissions, emergency room visits] and patient-reported outcomes [including quality of life, nutritional status and impact of fistulae] measured at baseline and at 6 or 12 month intervals. A single PROM [IBD-Control questionnaire] was recommended in the Standard Set and minimum risk adjustment data collected at baseline and annually were included: demographics, basic clinical information and treatment factors.

CONCLUSIONS: A Standard Set of outcome measures for IBD has been developed based on evidence, patient input and specialist consensus. It provides an international template for meaningful, comparable and easy-to-interpret measures as a step towards achieving value-based healthcare in IBD.

来源:J Crohns Colitis,查看原文。版权归原作者所有。

参考来源

  1. Kim AH, Roberts C, Feagan BG, et al. Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease-an International, Cross-disciplinary Consensus. J Crohns Colitis. 2018. PMID: 29216349. doi:10.1093/ecco-jcc/jjx161

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。